Effect of number of medications on cardiovascular therapy adherence

Annals of Pharmacotherapy

Volumn 36, Issue 10, 2002, Pages 1532-1539

  Shalansky, Stephen J ^a   Levy, Adrian R ^a   Morand, Brenda R ^a   Marcotte, Alain ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Adherence; Cardiovascular medications; Number of medications

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NON PRESCRIPTION DRUG; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HEALTH SURVEY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYPHARMACY; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0036785314     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C044     Document Type: Article

References (54)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in subjects with severe heart failure. N Engl J Med 1999;341:709-17.
2. Brown DG, Zhao X-Q, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-92.
3. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in subjects with heart failure. N Engl J Med 1997;336:525-33.
4. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
5. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
6. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in subjects with chronic heart failure. N Engl J Med 1996;334:1349-55.
7. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in subjects with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
8. Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, et al. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995;332:1125-31.
9. Schectman G, Hiatt J. Drug therapy for hypercholesterolemia in subjects with cardiovascular disease: factors limiting achievement of lipid goals. Am J Med 1996;100:197-204.
10. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications. A cross-national study. JAMA 1998;279:1458-62.
11. Feenstra J, Grobbee DE, Jonkman FAM, Hoes AW, Stricker BH. Prevention of relapse in subjects with congestive heart failure: the role of precipitating factors. Heart 1998;80:432-6.
12. Struthers AD, Anderson G, MacFadyen RJ, Fraser C, MacDonald TM. Nonadherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays. Heart 1999; 82:584-8.
13. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Angiotensin-converting enzyme inhibitor compliance and dosing among subjects with heart failure. Am Heart J 1999;138:818-25.
14. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm 2000;57:139-45.
15. Coambs RB, Jensen P, Her MH, Ferguson BS, Jarry JL, Wong JSW, et al. Review of the scientific literature on the prevalence, consequences, and health costs of noncompliance and inappropriate use of prescription medication in Canada. Toronto, Ontario: Pharmaceutical Manufacturers of Association of Canada, 1995.
16. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1990;2:19-33.
17. McDermott MMC, Schmitt B, Wallner E. Impact of medication nonadherance on coronary heart disease outcomes. A critical review. Arch Intern Med 1997;157:1921-9.
18. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990;336:542-5.
19. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MR, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989;27:1159-66.
20. Paes AHP, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-7.
21. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
22. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and healthcare costs. Pharmacotherapy 2000;20:941-9.
23. Gerbino P. Patient compliance. Ann Pharmacother 1993;27(suppl):S3-19.
24. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997;102(2A):43-9.
25. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001;13:27-40.
26. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998;20:764-71.
27. Coons SJ, Sheahan SL, Martin SS, Hendrick J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994;16:110-7.
28. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly subjects receiving home health services following hospital discharge. Ann Pharmacother 2001;35:539-45.
29. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
30. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154:433-7.
31. Mayo E. The human problems of an industrial civilization. New York: MacMillan, 1933.
32. Wickstrom G, Bendix T. The "Hawthorne effect"-what did the original Hawthorne studies actually show? Scand J Work Environ Health 2000; 26:363-7.
33. PharmaNet. British Columbia Ministry of Health [cited 2002 Jan 31]. Available from: URL:http://www.hlth.gov.bc.ca/pharme/net.html.
34. Levy AR, O'Brien BJ, Sellors C, Grootendorst PV, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharm 2002, in press.
35. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-64.
36. Anderson GM, Kerluke KJ, Pulcin IR. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program. Inquiry 1993;30:199-207.
37. Christensen DB, Williams B, Goldberg H, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997;35:1164-70.
38. Hamilton RA, Briceland LL. Use of prescription refill records to assess patient compliance. Am J Public Health 1992;49:1691-6.
39. Monane M, Bohn R, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the role of age, gender and race. Am J Public Health 1996;86:1805-8.
40. Hosmer DW, Lemeshow S. Applied logistic regression. 1st ed. New York: John Wiley and Sons, 1989.
41. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201-10.
42. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.
43. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medication treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-7.
44. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001;33:865-72.
45. Venturini F, Nichol MB, Sung JCY, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 1999;33:281-8.
46. Proctor VE, Tesfa A, Tompkins DC. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS. AIDS Patient Care STDS 1999;13:535-44.
47. Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomised controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 1999;159:2312-6.
48. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV subjects. AIDS Care 2000;12:387-98.
49. Horne R, Weinman J. Subjects' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67.
50. Ziguras SJ, Klimidis S, Lambert TJ, Jackson AC. Determinants of antipsychotic medication compliance in a multicultural population. Community Ment Health J 2001;37:273-83.
51. Carney RM, Freedland KE. Adherence to a prophylactic medication regimen in subjects with symptomatic versus asymptomatic ischemic heart disease. Behav Med 1998;24:35-9.
52. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore: Johns Hopkins Press, 1979.
53. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
54. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.